Skip to Main Content
Apollo Therapeutics
  • Company
  • About
  • Team
  • Contact
  • News

News

Press Releases

September 6, 2023

Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital

November 14, 2022

Apollo Therapeutics and The Institute of Cancer Research enter into collaboration for cancer drug development

August 1, 2022

Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics

Recent Press

August 1, 2022

Apollo lands inflammatory antibody from Avalo for $90M biobucks

Endpoints | June 17, 2021

A UK biotech looks to bring alliance between GSK, J&J, AstraZeneca, and top universities stateside with its first megaround

Fiercebiotech | June 17, 2021

Apollo Therapeutics to go ‘full throttle’ with $145M raise after 5 years under the radar

Website built by: 3 Media Web Solutions, Inc. ©2023 Apollo Therapeutics | All Rights Reserved.
Privacy and Cookies Policy
info@apollotherapeutics.com